Rating Change
B of A Securities analysts upgraded Pharvaris N.V. (NASDAQ:PHVS) from Neutral to Buy on October 23, 2026.
upgradeNASDAQ:PHVS
Pharvaris N.V. (PHVS) Upgraded to Buy at B of A Securities
B of A Securities analysts upgraded Pharvaris N.V. (NASDAQ:PHVS) from Neutral to Buy on October 23, 2026.
At publication ·
What changed
Pharvaris N.V. (NASDAQ:PHVS) · upgrade
- Firm
- B of A Securities
- Rating
- Neutral to Buy
- Price at event
- $31.48
- Market capitalization
- $1.6B
At a glance
Key takeaways
- B of A Securities upgraded Pharvaris N.V. (PHVS) from Neutral to Buy on October 23, 2026, suggesting analysts see improving fundamentals or favorable risk-reward dynamics.
Market Context
Pharvaris N.V. operates in the Healthcare sector. The stock currently trades at $31.48 with a market capitalization of $1.6B.
Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. B of A Securities's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Pharvaris N.V.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 23, 2026 | B of A Securities | Buy | N/A |
| Sep 10, 2026 | Guggenheim | Buy | N/A |
| Sep 09, 2026 | Morgan Stanley | Overweight | N/A |
| Sep 09, 2026 | Leerink Partners | Outperform | N/A |
| Sep 09, 2026 | Wells Fargo | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View PHVS Stock Page
Frequently Asked Questions
What does the Buy rating mean for PHVS?
A rating of Buy from B of A Securities reflects the analyst's outlook on Pharvaris N.V. (NASDAQ:PHVS). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PHVS forecast page.